Skip to main content

CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14

  • Protocol
  • First Online:
Cell Penetrating Peptides

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2383))

Abstract

Gene editing is increasing its popularity day by day especially as an essential tool for the research. It is based on two recombination mechanisms in mammalian cells: nonhomologous end-joining (NHEJ) and homology-directed repair (HDR). The first one can be used to silence a specific gene or a portion of it and the second one to insert new DNA, in presence of a donor template, in a targeted position in the genome. In order to exploit one of these two mechanisms, three major targeted nucleases have been developed: zinc-finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), and CRISPR-Cas (clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein). The last one seems to be the most promising tool among the others for gene editing. By using the properties and versatility of the Cell Penetrating Peptide (CPP) PepFect14, we developed a protocol to deliver a plasmid encoding for CRISPR-Cas9 and Green Fluorescent Protein (GFP) in BHM cell line expressing luciferase (Bomirsky Hamster Melanoma pLuc). Aiming to knocking down the luciferase gene in the cell line and to expressing GFP. Having two fast and easy read-outs of the plasmid’s activity at the same time. Furthermore, by labeling the CRISPR plasmid with Cy5 it is possible to have a visual confirmation of the cellular uptake of the pDNA/CPP complex, via fluorescent microscopy, as described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Porteus MH, Carroll D (2005) Gene targeting using zinc finger nucleases. Nat Biotechnol 23:967–973

    Article  CAS  Google Scholar 

  2. Christian M, Cermak T, Doyle EL et al (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757–761

    Article  CAS  Google Scholar 

  3. Ru R, Yao Y, Yu S et al (2013) Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs. Cell Regen 2:5

    Article  CAS  Google Scholar 

  4. Liu J, Gaj T, Patterson JT et al (2014) Cell-penetrating peptide-mediated delivery of talen proteins via bioconjugation for genome engineering. PLoS One 9:e85755

    Article  Google Scholar 

  5. Liu J, Gaj T, Wallen MC et al (2015) Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids 4:e232

    Article  CAS  Google Scholar 

  6. Jinek M, Chylinski K, Fonfara I et al (2012) A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821

    Article  CAS  Google Scholar 

  7. Shalaby K, Aouida M, El-Agnaf O (2020) Tissue-specific delivery of CRISPR therapeutics: strategies and mechanisms of non-viral vectors. Int J Mol Sci 21:E7353

    Article  Google Scholar 

  8. Ramakrishna S, Dad A-BK, Beloor J et al (2014) Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res 24:1020–1027

    Article  CAS  Google Scholar 

  9. Ha JS, Byun J, Ahn D-R (2016) Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption. Sci Reports 6:22847

    CAS  Google Scholar 

  10. Lostalé-Seijo I, Louzao I, Juanes M et al (2017) Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition. Chem Sci 8:7923–7931

    Article  Google Scholar 

  11. Del’Guidice T, Lepetit-Stoffaes J-P, Bordeleau L-J et al (2018) Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells. PLoS One 13:e0195558

    Article  Google Scholar 

  12. Chung JY, Ain QU, Song Y et al (2019) Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance. Genome Res 29:1442–1452

    Article  CAS  Google Scholar 

  13. He X-Y, Liu B-Y, Peng Y et al (2019) Multifunctional vector for delivery of genome editing plasmid targeting β-catenin to remodulate cancer cell properties. ACS Appl Mater Interfaces 11:226–237

    Article  CAS  Google Scholar 

  14. Krishnamurthy S, Wohlford-Lenane C, Kandimalla S et al (2019) Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. Nat Commun 10:4906

    Article  Google Scholar 

  15. Helmfors H, Eriksson J, Langel Ü (2015) Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotides. Anal Biochem 484:136–142

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Swedish Research Council.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Falato, L., Vunk, B., Langel, Ü. (2022). CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14. In: Langel, Ü. (eds) Cell Penetrating Peptides. Methods in Molecular Biology, vol 2383. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1752-6_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1752-6_38

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1751-9

  • Online ISBN: 978-1-0716-1752-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics